NCT02688088 2022-10-18A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyEli Lilly and CompanyPhase 1 Completed48 enrolled 30 charts
NCT01517399 2019-02-12Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer SubjectsDaiichi SankyoPhase 1 Completed28 enrolled